# Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes

> **NCT01691079** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 20 (actual)

## Conditions studied

- Bronchospasm, Exercise-Induced

## Interventions

- **DRUG:** ipratropium bromide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01691079
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01691079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01691079, "Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01691079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*